Zeynep Irem Ozay, Postdoctoral Research Fellow at Huntsman Cancer Institute, shared a post on X:
“Brilliant presentation by Sumanta K. Pal at ASCO25!
Genomic analysis from IMmotion010. High KIM-1/Teff shows longer DFS with adjuvant atezolizumab vs placebo”
More posts featuring ASCO25.
